Tag: <span>COVISHIELD</span>

Delta Variant: No Antibodies in 16% after Second Dose of Covishield, Says Study

Dhanraj SharmaJuly 4, 2021

Neutralising antibodies against the Delta variant (B1.617.2) were not observed in 58.1% of serum samples from those given one shot of the Oxford/AstraZeneca vaccine produced in India as Covishield, according...

INTERNATIONAL NEWS

India Made Covishield Vaccine Gets ‘Green Pass’ in Switzerland, 7 Other EU Nations

Dhanraj SharmaJuly 1, 2021

Amidst multiple setbacks from European drug regulators, Covishield vaccine, in a significant boost, has been accepted by Switzerland drug regulator along with seven other European countries. According to sources quoted...

NATIONAL NEWS

Centre issues SOPs for vaccination of persons undertaking international travel

CS SURBHI SAXENAJune 7, 2021

On several representations received by Union Ministry of Health & Family Welfare for allowing administration of second dose of Covishield for such persons who have only taken first dose of...

COVID-19

Aarogya Setu rolls out new feature to update Vaccination Status

CS SURBHI SAXENAJune 1, 2021

As per the press release by PIB, Aarogya Setu has rolled out a feature to update Vaccination Status on the Aarogya Setu App. Here is the step wise explanation of...

COVID-19

Serum Institute of India (SII) reduces price of COVID-19 vaccine COVISHILED from Rs 400 to Rs 300

CS SURBHI SAXENAApril 28, 2021

The Serum Institute of India has reduced the price of its COVID vaccine ‘ COVISHIELD’ from Rs 400 to Rs 300 per dose for states, as announced by CEO Adar...

Tag: COVISHIELD

Delta Variant: No Antibodies in 16% after Second Dose of Covishield, Says Study

India Made Covishield Vaccine Gets ‘Green Pass’ in Switzerland, 7 Other EU Nations

Centre issues SOPs for vaccination of persons undertaking international travel

Aarogya Setu rolls out new feature to update Vaccination Status

Serum Institute of India (SII) reduces price of COVID-19 vaccine COVISHILED from Rs 400 to Rs 300

Read on App

Hyundai Motor India Foundation announces roll-out of COVID-19 relief measures

FAQs for Patients with Hypertension, Diabetes and Heart Diseases in view of Coronavirus/COVID-19 Pandemic